Exchange: OTC·Updated 08:05 AM EDT

NWPHF Newron Pharmaceuticals Spa.

$20.00
$0.8874
(4.44%)
Pre-Market
Prev Close $20.00
EarningsMar 22
Mkt Cap$424.78M
Vol50.00

About NWPHF

Newron Pharmaceuticals SpA operates as a biopharmaceutical company. It focuses on the development of novel therapies for patients with diseases of the central and peripheral nervous system. The firm's products include Xadago (safinamide), Evenamide (NW-3509) and Ralfinamide. The company was founded by Luca Benatti, Ruggero Fariello and Patricia Salvati in 1999 and is headquartered in Bresso, Italy.
78

Extremely Bullish Sentiment

How do you feel about NWPHF?

Advertisement|Remove ads.